1 insider bought €7.8M of shares over the last 90 days, the latest by Manulife Private Credit Plus Fund, filed 25 Aug 2026.
This page follows insider dealings at John Hancock Marathon Asset-Based Lending Fund as filed with SEC (Form 4), a company from the Finance & Banking sector. Between 18 October 2025 and 18 October 2026, 4 insiders published 8 filings.
Open-market activity splits into 1 purchase totalling €7.8M and 1 sale totalling €852k; 1 insider sit on the buying side and 1 insider on the selling side. The net balance comes to €6.9M on the buying side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. One trade stands out by size: a purchase of €7.8M from Manulife Private Credit Plus Fund, disclosed on 25 August 2026. The buyers include 1 major shareholder.
The latest purchase dates back some time: it was published 54 days ago, on 25 August 2026. The median gap between a trade and its publication by SEC (Form 4) is 47 days. The legal deadline for a Form 4 is two business days after the transaction.
For context, the typical company on the same exchange (median of 5,458 companies) published 22 filings over the same period, against 8 filings here. Looking back to 2023, when coverage begins, insiders filed 8 purchases and 1 sale.
For comparison within the same sector, see the insider buying recorded at First Guaranty Bancshares, Inc. and BCB Bancorp Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
23 of 23 declarations
John Hancock Marathon Asset-Based Lending Fund (NYSE/NASDAQ: NA) is a U.S.-listed investment fund focused on alternative credit and asset-based lending. The vehicle is organized as a Massachusetts business trust and registered under the Investment Company Act of 1940. It operates as a continuously offered closed-end fund with periodic repurchases, giving it an interval-fund-like structure. The fund is based in the United States, with a business address in Boston, Massachusetts, while investment management is delivered in partnership with Marathon Asset Management, a New York-based specialist in public and private credit. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1885778/000168386325005571/f42425d1.htm?utm_source=openai))
The fund’s recent history dates to July 2022, when John Hancock Investment Management and Marathon Asset Management launched the product to broaden access to an institutional-grade asset-based lending strategy for accredited investors. In June 2023, John Hancock highlighted expanding availability of the fund, citing growing investor appetite for differentiated alternative assets that can provide diversification and current income. A further structural milestone came in December 2025, when the board approved a quarterly repurchase policy, an important development for liquidity, distribution positioning, and the fund’s overall operating framework. ([johnhancock.com](https://www.johnhancock.com/about-us/newsroom/news/john-hancock-investment-management/2022/07/john-hancock-investment-management-partners-with-marathon-asset-management-to-expand-alternatives-offerings-for-accredited-investors-with-asset-based-lending-fund.html?utm_source=openai))
Operationally, the fund targets high current income and, to a lesser extent, capital appreciation. Under normal circumstances, it invests at least 80% of net assets, plus borrowings for investment purposes, in asset-based lending investments. Its investable universe is intentionally broad and includes healthcare loans and royalty-backed credit, transportation assets, residential real estate lending, commercial real estate lending, consumer-related assets, corporate asset-based credit, and equipment financing. This breadth indicates an opportunistic credit strategy built around tangible collateral, cash-flow generation, and less efficiently priced segments of the market. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1885778/000119312525033378/d922353d486bpos.htm?utm_source=openai))
From a competitive standpoint, John Hancock Marathon Asset-Based Lending Fund benefits from the combination of the John Hancock distribution platform and Marathon Asset Management’s credit expertise. That pairing gives the fund a differentiated niche in alternative credit, distinct from conventional bond funds and designed to harvest complexity premia across private and semi-liquid lending markets. Its geographic footprint is primarily U.S.-anchored: the adviser/subadviser platform is centered in Boston and New York, while underlying exposures may span multiple industries and asset types. On the market side, the fund trades in the United States on the NYSE/NASDAQ ecosystem under ticker NA, which also means it is regularly subject to SEC reporting and insider-transaction disclosures such as Form 4 filings. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1279913/000149315226007154/xslF345X05/ownership.xml?utm_source=openai))
Purchases our model currently ranks for the recommendations list.
All recommendationsInsider filings
Over the last 90 days, 2 filings published between 13 August and 7 October 2026: no open-market purchase or sale filed by an insider. 2 other filings (not open-market purchases or sales: grants, options, plans, sale notices, block transfers).
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 13 October 2026 (UTC)